Sanofi (France) (SASY.PA) and Genzyme Biosurgery Investigational Oral Multiple Sclerosis Therapy Teriflunomide (Aubagio(TM)(*)) Significantly Reduced Relapse Rate, Disability Progression and Disease Activity
10/6/2011 6:59:56 AM
More...
|
Genzyme Biosurgery Shareholders Receive $64 Million Settlement in Victory Over Genzyme Corporation (GENZ)
1/13/2009 6:36:19 AM
More...
|
Genzyme Corporation (GENZ) Files for Approval of Single-Treatment Synvisc-One(TM)
6/20/2007 11:42:50 AM
More...
|
Genzyme Corporation (GENZ) Begins Phase 2 Gene Transfer Trial For Peripheral Arterial Disease
10/19/2005 5:12:49 PM
More...
|
Genzyme Corporation (GENZ) Completes Acquisition Of ILEX Oncology, Inc. (GENZ)
10/19/2005 5:12:30 PM
More...
|
Genzyme Corporation (GENZ) Recognized As A Top Employer By Scientists For Second Consecutive Year
10/19/2005 5:12:19 PM
More...
|
Genzyme Corporation (GENZ) Reports Strong Fourth-Quarter Revenue Growth
10/19/2005 5:12:12 PM
More...
|
Genzyme Corporation (GENZ) Completes Purchase Of Synvisc Sales and Marketing Rights
10/19/2005 5:11:56 PM
More...
|
Ash Stevens Inc. To Manufacture New Cancer Drug
10/19/2005 5:11:34 PM
More...
|
The Day In Review: Genentech, Inc. (DNA) Drives Biotech Higher
10/19/2005 5:10:53 PM
More...
|
|